These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3879695)

  • 1. Cytotoxicity of adherent mononuclear cells detached after 24 hours of culture.
    Cameron DJ
    Jpn J Exp Med; 1985 Dec; 55(6):239-43. PubMed ID: 3879695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity of temporarily adherent human mononuclear blood cells. 2. Characterization of effector cells.
    Eggen BM
    Acta Pathol Microbiol Immunol Scand C; 1982 Jun; 90(3):129-35. PubMed ID: 6981283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T lymphocyte induction of non-T cell-mediated nonspecific cytotoxicity. I. Introduction mechanisms.
    Mackler BF; O'Neill PA; Meistrich M
    Eur J Immunol; 1977 Feb; 7(2):55-61. PubMed ID: 326561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cytotoxic effector cells in preparations of adherent mononuclear cells from human peripheral blood.
    Freundlich B; Trinchieri G; Perussia B; Zurier RB
    J Immunol; 1984 Mar; 132(3):1255-60. PubMed ID: 6693767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antibody-independent cytotoxic activity of normal circulating human leucocytes. II. Failure to demonstrate effector cell-target cell interaction and target cell specificity of the circulating cytotoxic-enhancing factor.
    Richter M; Banerjee D; Sklar S
    Immunology; 1981 Sep; 44(1):109-18. PubMed ID: 6944271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous cytotoxicity of human peripheral blood mononuclear cells toward red blood cell targets. II. Time-dependent loss of suppressor cell activity.
    Muchmore AV; Decker JM; Blaese RM
    J Immunol; 1977 Nov; 119(5):1686-9. PubMed ID: 303249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytolytic activity of mononuclear cells, T-lymphocytes and monocytes of the peripheral blood in patients with lung cancer].
    Speranskiĭ DL; Blokhina NG; Bykovskaia SN; Kupriianova TA
    Biull Eksp Biol Med; 1988 Jul; 106(7):68-70. PubMed ID: 3261176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous and induced cytotoxic properties of human adherent mononuclear cells: killing of non-sensitized and antibody-coated non-erythroid cells.
    Horwitz DA; Kight N; Temple A; Allison AC
    Immunology; 1979 Feb; 36(2):221-8. PubMed ID: 220181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxicity of temporarily adherent human mononuclear blood cells in monocyte monolayers.
    Eggen BM
    Int Arch Allergy Appl Immunol; 1983; 72(2):143-9. PubMed ID: 6192097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human mixed lymphocyte reaction responder and stimulator capacities of highly purified T- and non-T cells and the role of monocytes.
    Hokland P; Heron I
    Acta Pathol Microbiol Scand C; 1979 Jun; 87C(3):191-6. PubMed ID: 158284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of the cytotoxic response (CML) in man by precultured cells: association with a monocyte/macrophage cell fraction.
    Dubey D; Stux S; Yunis E
    Transplant Proc; 1979 Dec; 11(4):1833-7. PubMed ID: 161098
    [No Abstract]   [Full Text] [Related]  

  • 12. The cell-mediated lympholysis-inducing capacity of highly purified human monocytes and T lymphocytes in primary and secondary mixed leukocyte cultures.
    Spits H; de Vries JE; Terhorst C
    J Immunol; 1981 Jun; 126(6):2275-8. PubMed ID: 6453162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the relative cytotoxic effector cell capabilities and the proportions of cells bearing various surface markers in human tonsil and peripheral blood mononuclear cells.
    Hunninghake GW; Haynes BF; Parrillo JE; Fauci AS
    Clin Exp Immunol; 1978 Apr; 32(1):186-91. PubMed ID: 668191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression of the generation of cell-mediated cytotoxicity by suppressor cells after surgery.
    Miyazaki S; Akiyoshi T; Arinaga S; Koba F; Wada T; Tsuji H
    Clin Exp Immunol; 1983 Nov; 54(2):573-9. PubMed ID: 6228356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic cytotoxicity. II. In vitro arming of monocytes and T cells by a heat labile fraction of human plasma.
    Muchmore AV; Decker JM; Blaese RM
    J Immunol; 1979 Mar; 122(3):1152-5. PubMed ID: 312819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A monoclonal antibody reactive with human peripheral blood monocytes.
    Breard J; Reinherz EL; Kung PC; Goldstein G; Schlossman SF
    J Immunol; 1980 Apr; 124(4):1943-8. PubMed ID: 6988511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse red blood cell rosettes: human B and some T lymphocytes express receptors for mouse erythrocytes in the presence of Ficoll.
    Eremin O; Binns RM
    Immunology; 1982 Oct; 47(2):321-7. PubMed ID: 6981591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of human peripheral blood colony forming cells (CFUC).
    Goldberg J; McGuire LA; Dock NL; Williams WJ; Davey FR
    Exp Hematol; 1980 Oct; 8(9):1086-93. PubMed ID: 7014236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of glass adherent human mononuclear cells.
    Koller CA; King GW; Hurtubise PE; Sagone AL; LoBuglio AF
    J Immunol; 1973 Nov; 111(5):1610-2. PubMed ID: 4583079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.